First LEA assay launched

LEA2 MPS Panel Our first LEA2 (Lysosomal Enzyme Activity) assay has now been started and with it several mucopolysaccharidoses (MPS) can be diagnosed from one… Read more

Novel diagnostics for Rare Disorders: Fabry in females, presented at WorldSymposium

The parallel measurement of lyso-GL-3 (lyso-Gb3) for Fabry disease is of high importance particularly for potential female Fabry patients, otherwise women at risk might be… Read more

5 years ARCHIMEDlife – Thanks to our partners, clients and friends!

The 21st of November 2017  is ARCHIMEDlife´s 5th anniversary, a proof that out of an idea you can evolve a successful company with dedicated people… Read more

Become part of our readers´ community

You can easily subscribe to our bi-monthly ARCHIMEDlife Newsletter and read about laboratory diagnostics, research studies, scientific publications and rare diseases – first hand and… Read more

We were there: Asia-Pacific Conference on Human Genetics

We took part in the 12th Asia-Pacific Conference on Human Genetics “Genomic Medicine and Clinical Practice” from 8th to 10th of November in Bangkok. Medical… Read more

Pharmaboardroom.com: Interview with ARCHIMEDlife CEO David Kasper in Austria issue of “Healthcare and Life Sciences Review”

Pharmaboardroom.com interviewed ARCHIMEDlife CEO David Kasper for their latest Austria issue of “Healthcare and Life Sciences Review”. Find out why he founded ARCHIMEDlife in a… Read more